Le Lézard
Classified in: Health
Subject: PER

Lorrie A. Carr Appointed as CEO for Excelera



MINNEAPOLIS, July 16, 2018 /PRNewswire/ -- "After a thorough and deliberate selection process, the Board of Directors is delighted that Lorrie will lead Excelera as we navigate the dynamic and evolving specialty pharmacy industry," said Robert Beacher, Chairman of the Board and interim CEO for Excelera. "Lorrie has a very diverse background within the biopharma and specialty pharmacy sectors, which will allow her to build upon our industry-leading position supporting our Members in caring for complex patients. I have no doubt that she is the right person to lead Excelera into new and innovative growth opportunities."

Prior to joining Excelera, Ms. Carr was the Chief Commercial Officer for ZappRx ? a healthcare technology company whose mission is to alleviate barriers that prevent patient access to life-saving specialty medications. Before ZappRx, Ms. Carr held an executive role within Walgreens Specialty Pharmacy as the Divisional VP of Enterprise Specialty Sales and Product Management. Ms. Carr started her career in the biopharmaceutical industry where she held leadership roles in global market access, reimbursement, managed care, marketing and network development.

"It is my great privilege to have been chosen to lead an innovative specialty healthcare company like Excelera," said Carr. "I am honored to have the opportunity to work with a team of very talented employees and an industry-leading Board of Directors. As CEO, my primary objectives will be to continue the great work that has been started, develop innovative strategies designed to grow and leverage our membership, and build meaningful partnerships with biopharmaceutical clients."

Ms. Carr received her bachelor's degree from Columbia College and holds her MBA from UMASS Isenberg School of Management.

About Excelera 
ExceleraRx Corp. supports the Excelera® Specialty Pharmacy Network, a national network of specialty pharmacies based at health systems and academic medical centers, enabling member organizations to gain access to limited distribution drugs and restricted payer agreements. The Excelera network provides national-scale efficiency and collaboration to improve quality and value of outpatient specialty drug therapy. For a current list of Excelera specialty pharmacy network members, or for more information about becoming a member of the Excelera network, visit excelerarx.com or follow us on LinkedIn.

 

ExceleraRx Corp. Logo

SOURCE ExceleraRx Corp.


These press releases may also interest you

at 22:04
Aurora Cannabis Inc. ("Aurora" or the "Company") , announced today that it has filed an early warning report in respect to its holdings in The Green Organic Dutchman Holdings Ltd. ("TGOD"), a company with a head office at 6025 Airport Road,...

at 21:48
Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based in South Korea, announced today that it has been ranked on...

at 21:00
Sports Medicine Devices Market by Product (Orthopedics Devices, Body Reconstruction & Repair, Body Support & Recovery, Body Monitoring & Evaluation, and Accessories) and Application (Hand - wrist Injury, Shoulder Injury, Ankle - foot Injury,Arm -...

at 20:15
ChemioCare USA Inc. ("ChemioCare" or the "Company"), a biotech company focused on transforming patient outcomes in cancer supportive care, today announces a successful Drug Enforcement Administration (DEA) registration: ChemioCare's exclusive...

at 20:05
HOUSTON, Oct. 18, 2018 /PRNewswire-PRWeb/ -- Paul Vitenas, MD, FACS, founder of Vitenas Cosmetic Surgery, is honored to announce that his practice has been named one of the Top Cosmetic Surgery Practices in the United States. The prestigious...

at 20:05
CENTENNIAL, Colo., Oct. 18, 2018 /PRNewswire-PRWeb/ -- Tinnitus 911 Orphan Awareness recently highlighted an organization and individual who took two weeks out of their life to aid and educate rescued orphans. During a two-week mission trip to...




News published on 16 july 2018 at 13:03 and distributed by: